Advanced Flower Capital Inc. logo

Advanced Flower Capital Inc.(AFCG)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$3.32
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for AFCG

11/13/2026: AFCG (1-star) is currently NOT-A-BUY. Pass it for now.

Advanced Flower Capital Inc. is a specialty finance business development company that provides senior secured loans to established cannabis operators and lower middle-market enterprises. The company benefits from deep domain expertise and asset-backed collateral structures that historically support attractive lending yields. Its primary growth strategy centers on expanding its footprint into broader middle-market debt opportunities while maintaining its institutional standing in cannabis finance. However, investors face notable risks including borrower credit concentration, micro-cap share volatility, and regulatory uncertainties. The stock suits income-focused investors comfortable with specialty credit risk, requiring close monitoring of portfolio credit quality and loan performance.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitAs a specialty finance BDC, the company focuses primarily on income generation and credit yields rather than rapid capital appreciation.
Momentum investorMixed fitMomentum fit is conditional on a positive upturn signal and sustained technical momentum given small-cap volatility.
Value investorMixed fitThe stock trades at a low price-to-earnings multiple, though credit quality risks require careful fundamental scrutiny.
Dividend investorStrong fit while signal remains positiveThe company appeals to income seekers through regular quarterly dividend distributions backed by portfolio interest income.
Low-risk investorWeak fitExposure to micro-cap equity volatility, credit default risks, and regulatory cannabis headwinds creates high risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighMicro-cap status and low daily trading volumes lead to sharp equity price swings.
Valuation riskMedium / highUncertainty surrounding underlying loan valuations and credit performance can impact book value.
Competition risk (specialty finance & cannabis lending)Medium / highCompetition from alternative lenders for prime cannabis and middle-market borrowers can compress lending spreads.
Business qualityMediumExternal management structure and niche sector focus require diligent oversight of underwriting standards.
Dividend incomeMedium / highPayout sustainability depends directly on consistent interest collections and borrower solvency.
Execution riskMedium / highSuccessful execution of its BDC conversion and expansion into general lower middle-market lending is crucial.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 74.38M USD
Price to earnings Ratio 3.19
1Y Target Price 8
Price to earnings Ratio 3.19
1Y Target Price 8
Volume (30-day avg) 58.2K shares
Beta 1.03
52 Weeks Range 1.96 - 3.73
Updated Date 11/15/2026
52 Weeks Range 1.96 - 3.73
Updated Date 11/15/2026
Dividends yield (FY) 4.49%
Basic EPS (TTM) 1.04

Sector & Industry Intelligence

Sector

Financial Services

Constructive
Sentiment
Bullish
Momentum
BUY Breadth Improving
BUY participation
50.4%
Active BUY / eligible
61 / 121
30-Day BUY Count Change
+45
Market state
Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Asset Management

BUY participation
52.9%
Active BUY / eligible
9 / 17
30-Day BUY Count Change
+3

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Rolling Over
PRICE PATH

Rolling Over

The price momentum is slowing down and beginning to turn downward.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit 20%
Avg. Invested days 44
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
AFCG receives a 3-star rating based on the available scored pillars. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
AFCG has moderate overall fundamentals (3 stars), with moderate financial health, weak growth momentum, and solid ownership. In FY2025 versus FY2024, strong cash generation (FCF margin 35.9%) is partially offset by negative earnings growth (-223.2%), negative revenue growth (-39.6%), weak profitability (net margin -66.0%).

Financial Health Rating

★★★★★
AFCG's financial health is supported by moderate liquidity, including working-capital and asset support (WC/assets 0.0%). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
AFCG's growth profile is soft, with the least-weak measure being revenue growth at -39.6% FY2025 versus FY2024. By comparison, while earnings growth (-223.2%, negative) and free-cash-flow growth (-47.9%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 18.1% and approximately 54.2% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 45.79% supports management-shareholder alignment.

Top 5 Institutional Investors

CDC Financial, Inc. 8.02%
Jane Street Group LLC 1.87%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.98%
Susquehanna International Group, LLP 0.89%
GSA Capital Partners LLP 0.86%

Unit Economics (Per $1K Revenue)

★★★★★
AFCG generates approximately $907 of gross profit, $-436 of operating income, and $359 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins and weak cash conversion support a 3-star rating, while capital efficiency is weak.

Economic Dimensions

★★★★★
Effective Tax Rate: 2.88%

Quantitative Style Profile

★★★★★
AFCG has a high-quality, liquid profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedQuality TiltSmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Cannabis Sector LendingInterest income and origination fees from senior secured loans extended to state-compliant cannabis operators.The core profit engine derives from high-yield debt provided to cannabis businesses unable to access traditional banking.
Lower Middle-Market LendingInterest and fee income generated from debt investments in non-cannabis operating companies.Diversification into broader middle-market credit aims to steady cash flows beyond a single regulated industry.

Earnings Date

Report Date 2026-11-05
When Before Market
Estimate 0.16
Actual 0.28

Profitability

Profit Margin 90.36%
Operating Margin (TTM) 37.89%

Management Effectiveness

Return on Assets (TTM) 7.05%
Return on Equity (TTM) 13.36%

Valuation

Trailing PE 3.19
Forward PE 4.3
Enterprise Value 168.97M
Price to Sales(TTM) 2.79
Enterprise Value 168.97M
Price to Sales(TTM) 2.79
Enterprise Value to Revenue 7.35
Enterprise Value to EBITDA -
Shares Outstanding 22.40M
Shares Floating 12.14M
Shares Outstanding 22.40M
Shares Floating 12.14M
Percent Insiders 45.79
Percent Institutions 18.13

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.